Raia Drogasil (OTCMKTS:RADLY) Posts Quarterly Earnings Results, Hits Expectations

Raia Drogasil (OTCMKTS:RADLY) released its earnings results on Tuesday. The company reported $0.05 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.05, Zacks reports.

Raia Drogasil Trading Up 3.3%

Raia Drogasil stock traded up $0.12 on Tuesday, hitting $3.77. The company’s stock had a trading volume of 2,842 shares, compared to its average volume of 54,849. The company has a fifty day moving average price of $3.56 and a 200-day moving average price of $4.23. Raia Drogasil has a one year low of $2.62 and a one year high of $5.34.

Wall Street Analysts Forecast Growth

Separately, Zacks Research raised Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Raia Drogasil Company Profile

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.